Skip to main content
Log in

Comparison of twice-daily and four-times daily administration of beclomethasone dipropionate in patients with severe chronic bronchial asthma

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Twice-daily and four-times daily treatment with beclomethasone dipropionate aerosol were compared in a double dummy crossover study in patients with severe chronic bronchial asthma. The trial consisted of two two-month treatment periods preceded by a two-week baseline period. No significant difference was found in the morning or evening PEF, in symptom scores for wheeze, cough, sputum, sleep disturbance, limitation of daily activity, rhinitis, daily usage of bronchodilator aerosol or requirement for additional oral corticosteroids. The study has confirmed that in management of severe bronchial asthma, a twice-daily regimen of beclomethasone dipropionate aerosol is as effective as four-times daily treatment, if the total daily dose of beclomethasone dipropionate is kept unchanged.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Björkander J, Formgren H, Johansson SÅ, Millqvist E (1982) Methodological aspects on clinical trials with inhaled corticosteroids: Results of two comparisons between two steroid aerosols in patients with asthma. Eur J Respir Dis 63 [Suppl 122]: 108–117

    Google Scholar 

  • Lahdensuo A, Alanko K, Poppius H, Härkönen M (1974) A comparative study of the efficacy of inhaled beclomethasone and systemic prednisolone in bronchial asthma. Scand J Respir Dis 55: 309–319

    Google Scholar 

  • Martin LE, Harrison C, Tanner RJN (1975) Metabolism of beclomethasone diproprionate by animals and man. Postgrad Med J 51 [Suppl 4]: 11–20

    Google Scholar 

  • Mecoy RJ, Laby B (1980) Beclomethasone dipropionate in twice daily treatment of asthma. Aust Fam Physician 9: 721–728

    Google Scholar 

  • Munch E, Gomez G, Harris C, Lack RP, Edwards VA, O'Connor P, Snowden DV, Mygind N (1981) An open comparison of dosage frequencies of beclomethasone dipropionate in seasonal allergic rhinitis. Clin Allergy 11: 303–309

    Google Scholar 

  • Munch EP, Taudorf E, Weeke B (1982) Dose frequency in the treatment of asthmatics with inhaled topical steroid. Eur J Respir Dis 63 [Suppl 122]: 143–153

    Google Scholar 

  • Nuutinen J, Ruoppi P, Sorri M, Suonpää J, Vainio-Mattila J (1983) Two-dose beclomethasone dipropionate in the treatment of seasonal allergic rhinitis. Rhinology 21: 165–172

    Google Scholar 

  • Toogood JH, Baskerville JC, Jennings B, Lefcoe NM, Johansson SÅ (1982) Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol 70: 288–298

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tukiainen, H., Vaara, J., Terho, E. et al. Comparison of twice-daily and four-times daily administration of beclomethasone dipropionate in patients with severe chronic bronchial asthma. Eur J Clin Pharmacol 30, 319–322 (1986). https://doi.org/10.1007/BF00541536

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00541536

Key words

Navigation